The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y.sub.1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y.sub.1 receptor activity.

 
Web www.patentalert.com

< Stable oxaliplatin formulation

> Process for preparing forms of atorvastatin calcium substantially free of impurities

> Expression of plasminogen and microplasminogen in duck weed
~ 00589